A Study to Assess the Efficacy and Safety of ASP1941 in Japanese Type 2 Diabetes Patients

NCT01057628 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

130

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: ipragliflozin
DRUG: placebo

Sponsor

Astellas Pharma Inc